Skip to content
Disability, Medical Health Aged Care

Autoimmunity art: Making science accessible for blind and low-vision audiences

Monash University 2 mins read

Activating art and technology to explore the science of autoimmunity, the Monash Biomedicine Discovery Institute will host a free sensory exhibition tomorrow (Friday 30 June) curated specifically for blind, low-vision and diverse needs audiences. 

 

Designed for all ages and levels of science literacy, the Monash Sensory Science Exhibition - Autoimmunity will explore eight autoimmune diseases through multi-sensory, multi-modal artworks and tactile displays, offering an accessible and inclusive learning opportunity.   

 

From handcrafted immune cells made of clay, food, paper and fabrics, to technologies and interactive displays exploring autoimmune processes, participants will learn about the ways in which the body mistakenly attacks its own organs and tissues, resulting in health conditions such as type 1 diabetes, multiple sclerosis and celiac disease.

 

Held in the award-winning Learning and Teaching Building on the Monash Clayton campus, participants will hear from Professor Jamie Rossjohn, a Monash University T cell immunology expert, then choose from sessions exploring various diseases in depth.

 

Professor Rossjohn said that autoimmune disorders impacted about five per cent of the population, with more women generally affected than men. The exhibition provided an opportunity for awareness-raising through a highly creative and dynamic experience.

 

“I’m delighted to take part in the Monash Sensory Science Exhibition,” he said. “I look forward to sharing information and learnings on autoimmunity, the body and how researchers are working to find better treatment options and cures.”

 

Supported by volunteers, participants will learn through handling artworks, touching tactile displays and hearing research experts on the topic.

 

First held in 2018, the exhibition is an initiative of the Rossjohn Laboratory, a research group pursuing the advancement of knowledge of innate and adaptive immunity, led by Professor Rossjohn. Dr Erica Tandori, a legally blind artist, researcher and academic and the artist-in-residence in the Rossjohn Laboratory, has led the development of the artworks and displays.

 

Dr Tandori said that the exhibition provided a unique opportunity for participants to explore science through the power of art.

“Scientists already use art to make medical concepts tangible and tactile without even realising, such as when they create 3D models of organs or cells,” she said.

 

“In our exhibition, we’re celebrating and highlighting the unique way in which art can make science accessible to people with different learning needs, and especially to blind and low vision audiences who face multiple barriers to participation. Everybody has a right to know how their bodies work, and to enjoy the opportunity to learn about science in ways that suit their needs.”      

 

Event details: Monash Sensory Science Exhibition - Autoimmunity

 

Location:

 

Monash University

Learning and Teaching Building,

19 Ancora Imparo Way

Clayton Campus

 

Date: Friday 30 June 2023

 

Time: 9am–2pm.

 

For media enquiries please contact:

Monash University

Cheryl Critchley - Communications Manager (medical)
E: [email protected]
T: +61 (0) 418 312 596

For more Monash media stories, visit our news and events site

For general media enquiries please contact:
Monash Media
E: [email protected]
T: +61 (0) 3 9903 4840

Media

More from this category

  • Medical Health Aged Care, Women
  • 04/03/2026
  • 06:00
Australia New Zealand Gynaecological Oncology Group (ANZGOG)

STRIVE clinical trial now available in Aotearoa New Zealand to improve outcomes in vulvar cancer

MEDIA RELEASE: Wednesday,4March2025 The Australian New Zealand Gynaecological Oncology Group (ANZGOG) in partnership with the Canadian Cancer Trials Group (CCTG) announces the local opening of theSTRIVEclinical trial– Stratification of Vulvar Squamous Cell Carcinoma by HPV and p53 status to Guide Excisionclinical trial (CCTG Protocol VU.2; ANZGOG Protocol ANZGOG2109/2021). STRIVErepresentsan important stepforward in advancing evidence-based surgical management for women diagnosed with vulvar squamous cell carcinoma (VSCC). About the STRIVE Trial STRIVE is an international, prospective, stratification study designed to refine surgical decision-making for patients withprimary vulvar squamous cell carcinoma(VSCC) based ontumourbiology. The study is led globally by the CCTG and led…

  • Medical Health Aged Care
  • 03/03/2026
  • 21:26
SAV-IOL

Lucidis® Sets High Standards in Premium Cataract Surgery with Full-Range Vision Performance

NEUCHÂTEL, Switzerland–BUSINESS WIRE– Swiss Advanced Vision announces new clinical evidence confirming the exceptional performance of its Lucidis® intraocular lens (IOL), strengthening its position as…

  • Contains:
  • Medical Health Aged Care
  • 03/03/2026
  • 15:48
Dementia Australia

Memory Walk & Jog Adelaide just weeks away!

The 2026 Adelaide Memory Walk & Jog is only a few short weeks away, with the event taking place on Sunday 15 March at Wigley Reserve, Glenelg. Memory Walk & Jog returns to Adelaide in 2026, bringing the community together to get active for brain health and to show support for people impacted by dementia. Adelaide Memory Walk & Jog is a key Dementia Australia community event, helping raise funds to deliver invaluable support, education and resources for people living with dementia, their families and carers. Memory Walk & Jog is about being part of the community and feeling supported.…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.